Literature DB >> 12474644

Medical evaluation of nephrolithiasis.

Hans-Göran Tiselius1.   

Abstract

A careful and individualized evaluation of risk factors is a fundamental part of the management of patients with urinary tract stone disease. Identification and correction of important abnormalities provide the basis for designing an efficient and rational treatment program, aiming at an arrest or at least reduction of recurrent stone formation. It is beyond doubt that appropriate therapeutic steps in this regard are of great benefit for the patient. It needs to be emphasized, however, that no success will be obtained unless the patient is willing and able to follow the ensuing dietary recommendations and medical advice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12474644     DOI: 10.1016/s0889-8529(02)00027-0

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  11 in total

Review 1.  Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

2.  Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men.

Authors:  Kang Chen; Dong Chen; Chuangxin Lan; Xiongfa Liang; Tao Zeng; Jian Huang; Xiaolu Duan; Zhenzhen Kong; Shujue Li; Hans-Göran Tiselius; Alberto Gurioli; Xiaogang Lu; Guohua Zeng; Wenqi Wu
Journal:  Int Urol Nephrol       Date:  2017-10-19       Impact factor: 2.370

Review 3.  ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.

Authors:  T M Reynolds
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

Review 4.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

5.  Metabolic disturbances in Chinese children with urolithiasis: a single center report.

Authors:  Dong Yang; Hans-Göran Tiselius; Chuangxin Lan; Dong Chen; Kang Chen; Lili Ou; Yang Liu; Shaohong Xu; Guohua Zeng; Ming Lei; Wenqi Wu
Journal:  Urolithiasis       Date:  2016-08-10       Impact factor: 3.436

6.  Evaluation of pediatric nephrolithiasis.

Authors:  Paul J Kokorowski; Katherine Hubert; Caleb P Nelson
Journal:  Indian J Urol       Date:  2010-10

7.  Difference in 24-Hour Urine Composition between Diabetic and Non-Diabetic Adults without Nephrolithiasis.

Authors:  Wei Zhu; Zanlin Mai; Jing Qin; Xiaolu Duan; Yang Liu; Zhijian Zhao; Jian Yuan; Shaw P Wan; Guohua Zeng
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

8.  Impact of dyslipidemia on 24-h urine composition in adults without urolithiasis.

Authors:  Chao Cai; Zanlin Mai; Tuo Deng; Zhijian Zhao; Wei Zhu; Yaoan Wen; Xiaolu Duan; Wenqi Wu; Guohua Zeng
Journal:  Lipids Health Dis       Date:  2018-11-06       Impact factor: 3.876

Review 9.  Economics of stone disease/treatment.

Authors:  Walter Ludwig Strohmaier
Journal:  Arab J Urol       Date:  2012-03-22

10.  Influence of weight status on 24-hour urine composition in adults without urolithiasis: A nationwide study based on a Chinese Han population.

Authors:  Tuo Deng; Zanlin Mai; Chao Cai; Xiaolu Duan; Wei Zhu; Tao Zhang; Wenqi Wu; Guohua Zeng
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.